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Abstract

Keywords

Objective. Atrial fibrillation (AF) in type 2 diabetes mellitus (T2DM) has been little explored so far.
However, there are several cardio metabolic risk factors for AF in T2DM patients, such as arterial
hypertension, obesity or the metabolic syndrome. Our objective was to evaluate cardio metabolic risk factors
for AF in T2DM patients. Methods. We studied the medical records of T2DM patients hospitalized in the
Internal Medicine department of an emergency referral hospital in Bucharest, Romania. The study was
observational, retrospective and carried out between January-June 2018. Results. The study group included
221 T2DM patients (with a mean age of 68.65 ± 10.64, ranging between 37-93 years): 116 women (52.49%;
with a mean age of 70.53 ± 10.69, ranging between 37-93 years) and 105 men (47.51%; with a mean age of
66.57 ± 10.23, ranging between 38-91 years). 92 patients had AF (41.63%): 40 women (34.48%) and 52 men
(49.52%). 180 patients (81.45%) were hypertensive: 103 women (88.79%) and 77 men (73.33%). 113
patients (51.13%) had metabolic syndrome: 58 women (50.00%) and 55 men (52.38%). 77 patients (34.84%)
were obese: 45 women (38.79%) and 32 men (30.48%). AF patients associated obesity in 26 cases (28.26%),
hypertension in 73 cases (79.35%) and metabolic syndrome in 56 cases (60.87%). Conclusions. Out of the
study group, 92 T2DM patients (41.63%) had AF, men being more likely to suffer from AF than women
(p=0.0288). Hypertension affected 180 patients (81.45%) and in greater proportion women vs. men
(p=0.0051). The metabolic syndrome and obesity were discovered in 113 patients (51.13%) and 77 patients
(34.84%), respectively, with no significant differences in terms of gender. In our research, the highest cardio
metabolic risk factors for AF in T2DM were hypertension (OR = 3.6675) and the metabolic syndrome (OR =
3.3388).



diabetes mellitus, atrial fibrillation, hypertension, obesity, metabolic syndrome, risk
factors.

Highlights

 Patients with type 2 diabetes mellitus are at increased risk of developing atrial fibrillation.
 Hypertension, metabolic syndrome and obesity are important cardio metabolic risk
factors for atrial fibrillation in patients with type 2 diabetes mellitus.
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Introduction
Out of the cardiac arrhythmias, atrial fibrillation (AF)
is undoubtedly the most frequently encountered entity in
clinical practice (1). The number of patients with AF has
been growing steadily up to the point in which this
disorder has become an epidemic: in 2030, more than 12
million people will be affected by AF in the United States
(1, 2).
Age, male sex, type 2 diabetes mellitus (T2DM),
obesity, hypertension, heart failure and metabolic
syndrome are some of the risk factors involved in the
development of AF (3-5). The relationship between
T2DM and AF is complex and of particular interest. A
recent Danish cohort study, conducted on 253.374 T2DM
patients vs. 4.827.713 subjects without T2DM, has
postulated that, in the development of AF, T2DM is an
independent risk factor and that younger subjects with
T2DM are at higher risk of AF vs. elderly T2DM subjects
(6).
The cardio metabolic risk factors for AF have been
intensively studied in the past decade and particular
attention has been paid to the metabolic syndrome. Many
studies have shown conflicting results regarding the
impact of the metabolic syndrome on AF development,
with some suggesting that AF is rather linked to some
components of the metabolic syndrome rather than to the
metabolic syndrome itself (5). The metabolic syndrome,
defined as the co-occurrence of several metabolic risk
factors in a single patient, can be easily diagnosed in a
routine check-up and it is a common finding among
Romanian patients, some studies reporting a prevalence
>65% (7).
Thus, our objective was to evaluate cardio metabolic
risk factors for AF in T2DM patients, particularly
focusing on the metabolic syndrome, hypertension and
obesity.

Materials and Methods
Study design
A cross-sectional observational retrospective study
was conducted to evaluate cardio metabolic risk factors
for AF in patients diagnosed with T2DM.
Setting
The study was conducted from January to June 2018
in the Internal Medicine Clinic of a tertiary care teaching
center located in Bucharest, Romania.
Participants
A total of 221 patients were included in the study,
representing all patients diagnosed with T2DM who were
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referred to the Internal Medicine Clinic from January to
June 2018.
Data sources and variables
The data were collected by utilizing electronic medical
records of patients diagnosed with T2DM. The
information obtained from the medical records was
collected by means of a structured form that included:
age, sex, comorbidities and treatment.
Bias
To reduce selection bias, we included all patients
diagnosed with T2DM in the time period of the study.
Patients with incomplete medical records were excluded.
Statistical methods
Categorical variables were presented as frequencies
and percentages. Continuous variables were presented as
the mean ± SD. Patients were divided according to the
presence and absence of AF, metabolic syndrome, obesity
and hypertension. Categorical variables were compared
using Fisher’s exact test.
Continuous variables were compared using
independent t-test samples. The level of significance was
presented as p-values in different tables. The analysis was
performed at a 5% level of significance using Microsoft
Excel (Microsoft Office Professional Plus 2013),
MedCalc (https://www.medcalc.org) and GraphPad
QuickCalcs (https://www.graphpad.com).
Ethical standards
The study was conducted in accordance with the
national law and the Declaration of Helsinki (1975), as
revised in 2008 (5). All patients signed an informed
consent upon admission, agreeing to have their medical
records reviewed for scientific purposes as long as their
confidentiality is respected.

Results
The study group included 221 patients diagnosed with
T2DM (with a mean age of 68.65 ± 10.64, ranging
between 37-93 years): 116 women (52.49%; with a mean
age of 70.53 ± 10.69, ranging between 37-93 years) and
105 men (47.51%; with a mean age of 66.57 ± 10.23,
ranging between 38-91 years). 92 patients had AF
(41.63%): 40 women (34.48%) and 52 men (49.52%). 180
patients (81.45%) were hypertensive: 103 women
(88.79%) and 77 men (73.33%). 113 patients (51.13%)
had metabolic syndrome: 58 women (50.00%) and 55
men (52.38%). 77 patients (34.84%) were obese: 45
women (38.79%) and 32 men (30.48%). These results are
presented in Table 1.

Risk Factors for Atrial Fibrillation in Diabetes
Table 1. The characteristics of patients included
in the study
Women

Men

p-value

Age

70.53 ± 10.69
years

66.57 ± 10.23
years

0.0080

Number

116 (52.49%)

105 (47.51%)

-

Atrial
fibrillation

Yes
No
Yes

Hypertension
No
Metabolic
syndrome

Yes
No
Yes

Obesity
No

40
(34.48%)
76
(65.52%)
103
(88.79%)
13
(11.21%)
58
(50.00%)
58
(50.00%)
45
(38.79%)
71
(61.21%)

52
(49.52%)
53
No
(50.48%)
77
Yes
(73.33%)
28
No
(26.67%)
55
Yes
(52.38%)
50
No
(47.62%)
32
Yes
(30.48%)
73
No
(69.52%)
Yes

0.0288

0.0051

0.7879

0.2063

AF patients associated obesity in 26 cases (28.26%),
hypertension in 73 cases (79.35%) and the metabolic
syndrome in 56 cases (60.87%), as seen in Table 2 (OR =
odds ratio, CI = confidence intervals).

Discussions
In the current study, 221 patients with T2DM were
recruited over a period of six months based on the
medical records of the Internal Medicine Clinic of a
referral emergency hospital in Bucharest, Romania. Out
of this group, 92 patients (41.63%) had also been
diagnosed with AF, men being more likely to suffer from
AF than women (p=0.0288), as similar studies have
previously reported (8, 9). Hypertension affected 180
patients (81.45%), women in a greater proportion than
men (p=0.0051). The metabolic syndrome and obesity
were discovered in 113 (51.13%) and 77 patients
(34.84%), respectively, with no significant differences in

terms of gender. In our research, the highest cardio
metabolic risk factors for AF in T2DM were hypertension
(OR = 3.6675) and the metabolic syndrome (OR =
3.3388).
The management of both type 1 and type 2 diabetes
mellitus will still remain a challenge, even in the near
future: the prevalence of diabetes in the United States is
rapidly growing, with reports estimating that by 2030
more than 54.9 million people will suffer from diagnosed
or undiagnosed diabetes, as opposed to approximately
35.6 million people in 2015 (10). As compared to the
general population, patients diagnosed with T2DM are
more likely to suffer from AF as well: Zethelius et al.
investigated which are the risk factors for AF in T2DM
and concluded that there was a strong association between
obesity/body mass index, hypertension and albuminuria
and AF in T2DM (11).
The pathophysiology of AF in T2DM is complex.
Hyperglycemia and hypertension are key players in the
development of AF in patients with diabetes:
hyperglycemia leads to increased levels of inflammatory
markers, reactive oxygen species and advanced
glycosylation end products at a myocardial level,
promoting atrial fibrosis, whereas hypertension promotes
atrial dilatation (12). Atrial dilatation is also enhanced by
the proliferation of atrial fibroblasts. Both conditions lead
to structural and electrical remodeling of the left atrium
and explain the development of AF in T2DM (1, 13, 14).
The contribution of oxidative stress might also be
determined by additional exposure to exogenous sources
of ROS, as well as the reduced capacity of antioxidant
defense systems to scavenge these molecules in the
elderly since their efficiency is age-dependent (15,16).
Irrespective of its relationship with T2DM, AF should
be appropriately managed. Therapeutic solutions include
either rate control or rhythm control options and, in
patients with CHA2DS2-VASc score of at least one point,
anticoagulation agents should be prescribed to prevent
thromboembolism and cardiovascular mortality (1, 1719).

Table 2. Cardio metabolic risk factors for AF in T2DM
AF +
Hypertension

Metabolic syndrome
Obesity

AF -

Yes

73 (79.35%)

Yes

66 (51.16%)

No

19 (20.65%)

No

63 (48.84%)

Yes

56 (60.87%)

Yes

41 (31.78%)

No

36 (39.13%)

No

88 (68.22%)

Yes

26 (28.26%)

Yes

23 (17.83%)

No

66 (71.74%)

No

106 (82.17%)

OR

95% CI

p-value

3.6675

1.99-6.76

<0.0001

3.3388

1.91-5.84

<0.0001

1.8155

0.96-3.44

0.0677
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Conclusions
Cardio metabolic risk factors for AF (hypertension,
metabolic syndrome and obesity) were found in a
substantial percentage in the study group. Women were
more likely to be hypertensive than men. There were no
statistically significant differences between genders
regarding the metabolic syndrome or obesity. In the study
group, 41.63% of the patients diagnosed with T2DM also
associated AF. Diabetic men were more likely to have AF
than women. AF was strongly associated with
hypertension and metabolic syndrome in diabetic patients.
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